REQUEST A DEMO
Total
USD $0.00
Search more companies

Oxisalud S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Oxisalud S.A.S. Profile Updated: October 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Oxisalud S.A.S. is based in Colombia. The head office is in Medellin. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on April 23, 1998. 81 (2024) employees currently work for Oxisalud S.A.S.. From the latest financial highlights, Oxisalud S.A.S. reported a net sales revenue increase of 9.1% in 2023. Its’ total assets recorded a growth of 21.7%. The net profit margin of Oxisalud S.A.S. increased by 6.54% in 2023.

Headquarters
Calle 29 65 46
Medellin; Antioquia;

Contact Details: Purchase the Oxisalud S.A.S. report to view the information.

Website: http://oxisaludsas.com.co

Basic Information
Total Employees:
Purchase the Oxisalud S.A.S. report to view the information.
Outstanding Shares:
Purchase the Oxisalud S.A.S. report to view the information.
Incorporation Date:
April 23, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Oxisalud S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
9.1%
Total operating revenue
9.92%
Operating profit (EBIT)
69.61%
EBITDA
7.13%
Net Profit (Loss) for the Period
85.34%
Total assets
21.7%
Total equity
338.8%
Operating Profit Margin (ROS)
9.54%
Net Profit Margin
6.54%
Return on Equity (ROE)
-44.21%
Quick Ratio
0.1%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?